Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer

NCT02306954 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma

Interventions

BIOLOGICAL: High Dose IL-2
RADIATION: SBRT

Sponsor

Providence Health & Services

Collaborators

[object Object]
[object Object]